Clinical Trial Update: Assessment of Any Potential Retinal Effects of Tafenoquine (TQ) [Phase 1]

View source ↗

Summary

Phase 1 trial completed that assessed potential retinal effects of tafenoquine in patients with Plasmodium vivax malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Vivax | Phase 1 | Status: COMPLETED